Milošević Ivana, Jovanović Jaroslava, Stevanovic Olja
Faculty of Medicine, University of Belgrade, Serbia.
J Infect Dev Ctries. 2020 Nov 30;14(11):1248-1251. doi: 10.3855/jidc.13840.
We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor.
我们报告了一名患有布鲁顿无丙种球蛋白血症的34岁男性新型冠状病毒病（COVID-19）的非典型病程。该患者通过包括康复期血浆和白细胞介素-6（IL-6）抑制剂在内的现有药物联合治疗成功治愈。
